CME Group Stock Forecast, Price & News

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 2 sell ratings, 8 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CME Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
View analyst ratings for CME Group or view top-rated stocks.

Wall Street analysts have given CME Group a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CME Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

CME Group is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for CME Group.

CME Group Inc. (NASDAQ:CME) issued its quarterly earnings data on Wednesday, July, 28th. The financial services provider reported $1.64 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.59 by $0.05. CME Group had a net margin of 41.64% and a trailing twelve-month return on equity of 8.33%.
View CME Group's earnings history.

CME Group's stock was trading at $194.6750 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CME shares have increased by 6.6% and is now trading at $207.60.
View which stocks have been most impacted by COVID-19.

CME Group announced a quarterly dividend on Thursday, August 5th. Stockholders of record on Friday, September 10th will be paid a dividend of $0.90 per share on Monday, September 27th. This represents a $3.60 annualized dividend and a yield of 1.73%.
View CME Group's dividend history.

CME Group pays an annual dividend of $3.60 per share and currently has a dividend yield of 1.72%. CME Group does not yet have a strong track record of dividend growth. The dividend payout ratio of CME Group is 53.57%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME Group will have a dividend payout ratio of 49.86% next year. This indicates that CME Group will be able to sustain or increase its dividend.
View CME Group's dividend history.

14 equities research analysts have issued twelve-month target prices for CME Group's stock. Their forecasts range from $135.00 to $235.00. On average, they expect CME Group's share price to reach $200.83 in the next year. This suggests that the stock has a possible downside of 3.3%.
View analysts' price targets for CME Group or view top-rated stocks among Wall Street analysts.

144 employees have rated CME Group CEO Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among CME Group's employees.

Some companies that are related to CME Group include Moody's (MCO), Intercontinental Exchange (ICE), MSCI (MSCI), Nasdaq (NDAQ), Interactive Brokers Group (IBKR), MarketAxess (MKTX), Cboe Global Markets (CBOE), Arrow Financial (AROW), Marlin Business Services (MRLN) and California First Leasing (CFNB).
View all of CME's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), The Walt Disney (DIS), Visa (V), Netflix (NFLX), The Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include Parnassus Investments CA (1.71%), Alliancebernstein L.P. (0.73%), Sarasin & Partners LLP (0.52%), Cantillon Capital Management LLC (0.48%), Sumitomo Mitsui Trust Holdings Inc. (0.33%) and Intermede Investment Partners Ltd (0.27%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends for CME Group.

CME stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Alliancebernstein L.P., State of Alaska Department of Revenue, New York State Common Retirement Fund, Aegon Asset Management UK PLC, Cantillon Capital Management LLC, Kornitzer Capital Management Inc. KS, and Illinois Municipal Retirement Fund. Company insiders that have sold CME Group company stock in the last year include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, and Terrence A Duffy.
View insider buying and selling activity for CME Group or view top insider-selling stocks.

CME stock was bought by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Mn Services Vermogensbeheer B.V., Rathbone Brothers plc, MUFG Securities EMEA plc, Intermede Investment Partners Ltd, Russell Investments Group Ltd., Sarasin & Partners LLP, and Waverton Investment Management Ltd.
View insider buying and selling activity for CME Group or or view top insider-buying stocks.

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CME stock can currently be purchased for approximately $207.60.

CME Group has a market capitalization of $74.55 billion and generates $4.88 billion in revenue each year. The financial services provider earns $2.11 billion in net income (profit) each year or $6.72 on an earnings per share basis.

CME Group employs 4,370 workers across the globe.

CME Group was founded in 1848.

The official website for CME Group is www.cmegroup.com.

CME Group is headquartered at 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at (312) 930-1000 or via email at [email protected]